Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla M Jalbut

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|July 10, 2015
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER databaseAndrew M Brunner, Gabriela Hobbs, Marla M Jalbut, et al.
Joint Commission Journal on Quality and Patient Safety|April 30, 2022
Improving Adherence to Risk Stratification Guidelines Regarding Venous Thromboembolism ProphylaxisJürgen L Holleck, Marla M Jalbut, Benjamin A Rodwin, et al.
Leukemia Research Reports|May 15, 2015
Acute myeloid leukemia in a patient with constitutional 47,XXY karyotypeMarla M Jalbut, Aliyah R Sohani, Paola Dal Cin, et al.
Leukemia & Lymphoma|August 10, 2017
Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemiaMarla M Jalbut, Andrew M Brunner, Philip C Amrein, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2013
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseKang-Woo Lee, Joo-Young Im, Jong-Min Woo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|July 10, 2015
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER databaseAndrew M Brunner, Gabriela Hobbs, Marla M Jalbut, et al.
Joint Commission Journal on Quality and Patient Safety|April 30, 2022
Improving Adherence to Risk Stratification Guidelines Regarding Venous Thromboembolism ProphylaxisJürgen L Holleck, Marla M Jalbut, Benjamin A Rodwin, et al.
Leukemia Research Reports|May 15, 2015
Acute myeloid leukemia in a patient with constitutional 47,XXY karyotypeMarla M Jalbut, Aliyah R Sohani, Paola Dal Cin, et al.
Leukemia & Lymphoma|August 10, 2017
Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemiaMarla M Jalbut, Andrew M Brunner, Philip C Amrein, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2013
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseKang-Woo Lee, Joo-Young Im, Jong-Min Woo, et al.
Pageof 1